10 employees
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
2014
$16M
from 4 investors over 4 rounds
FDM Digital raised $16M on March 8, 2016
Investors: Osage University Partners (OUP), Data Collective, Advent Life Sciences and Medicxi